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Abst rac t
Introduction: The aim of periocular basal cell carcinoma (BCC) surgery is radical excision of the tumour while 
maintaining eyelid functionality and facial aesthetics. Differences in management of the patients after excision of 
eyelid BCC with a narrow margin are described in the literature.
Aim: This study concerns the correlation between the recurrence rate in the periorbital area and the narrow safety 
margin of excision in the histopathological report with respect to various clinical and histopathological features.
Material and methods: A retrospective non-randomized analysis was conducted on 158 patients with BCC of the 
periorbital area. These patients were operated on between January 2002 and December 2016. A database was 
created, comprised of patient age, sex, location of the lesion, TNM, method of reconstruction, result of the histo-
pathological examination, date and location of the recurrence.
Results: In 66 (41.77%) patients BCC was radically removed. In 50 (31.65%) patients BCC was removed with a narrow 
margin and in 42 (26.58%) cases, radical excision was not achieved. The recurrence rate was significantly higher 
in the aggressive BCC group compared to those with non-aggressive BCC (p = 0.004). The recurrence-free rate for 
non-aggressive subtypes was 98.11% in both the first and fifth years, but in aggressive subtypes it was 89.06% in 
the first year but fell to 80.16% in the fifth year.
Conclusions: An aggressive subtype of BCC significantly influences the risk of non-radical excision of the lesion. 
Aggressive BCC subtypes should have more frequent check-ups. There is no need to reoperate patients with a nar-
row margin of BCC excision.
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Introduction
Basal cell carcinoma (BCC) is the most common skin 
cancer occurring between the ages of fifty and seventy. 
About 80% of the changes are located in the head and 
neck area. Of these lesions, the BCC of the orbital region 
accounts for approximately 20% [1] and in the eyelid, 
10% [2]. The clinical symptom of BCC is a slowly growing 
nodule or ulcer usually located on the lower eyelid and 
in the medial canthal region of the eye, rarely metastasiz-
ing. Local recurrences vary from 0.39% to 4% and cause 
morbidity due to involvement of important functional 
structures (content of the orbit, eyeball, anterior skull 
base). Anatomic location in the H-zone and periorbital 
area has been known to be the risk factor for BCC recur-
rence. Also aggressive BCC subtypes such as micronodu-
lar, infiltrating, sclerosing, morpheaform tend to recur 
more often compared to the nodular subtype. According 
to the National Comprehensive Cancer Network (NCCN) 
2019, the treatment of choice for high-risk BCC is Mohs 
micrographic surgery (MMS) or complete circumferential 
peripheral and deep margin assessment with permanent 
or intraoperative frozen section analysis [3].
Aim
This study concerns the correlation between the re-
currence rate in the periorbital area and the narrow safe-
ty margin of excision in the histopathological report with 
respect to various clinical and histopathological features.
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Material and methods
A retrospective analysis was performed on a group 
of 158 patients with BCC of the periorbital area. The 
patients were operated on between January 2002 and 
December 2016 in the Department of Maxillofacial Sur-
gery of the Jagiellonian University in Krakow. Inclusion 
criteria were as follows: patients with primary BCC, and 
single neoplasm. Patients treated previously or at present 
for cancers in other locations as well as patients treated 
with immunosuppressants were not included into this 
study. The incisional and punch biopsies or recurrent le-
sions were excluded. The database included for each pa-
tient: age, sex, location of the lesion, TNM (NCCN 2019), 
method of reconstruction, the result of the histopatho-
logical examination, date and location of recurrence 
(if any), and date of the last follow-up visit.
All patients underwent standard surgical excision 
with a margin of 4 mm of surrounding healthy tissue as 
the safety margin (Figure 1). In some cases, an intraop-
erative histopathological examination was performed. 
Excised lesions were verified according to the 2006 WHO 
classification. All collected data were analysed according 
to the local recurrence rate. The specimens were divided 
into three groups on the basis of pathology results at the 
time of primary surgical removal: non-radical excision 
(positive, involved margin), excision with narrow margins 
< 2 mm, and radical excision with margin ≥ 2 mm. Ac-
cording to the NCCN 2019, the aggressive BCC included 
infiltrative, micronodular and morpheaform subtypes 
and the non-aggressive – nodular and superficial. Pres-
ence of vessels or nerves infiltration was not indicated in 
the histopathological report.
Statistical analysis
The Kaplan-Meier curves were used to determine 
the relapse-free survival rate. The comparison of Kaplan-
Meier curves was made using the log-rank test. The 
significance level of 0.05 was assumed in the analysis. 
Odds ratio was used to determine the risk of recurrence 
depending on the BCC subtype. The analysis was carried 
out in the R program, version 3.4.3.
Results
In our study we included 158 patients with histopath-
ologically confirmed primary BCC of the orbital region. 
There were 80 (50.63 %) males and 78 (49.37 %) females. 
The average age was 68 ±12.43. The time between the 
first symptoms observed by patients and a performed 
biopsy in the outpatient clinic was 45 months, with a me-
dian time of 24 months (12–60). In 88 (55.7%) patients, 
BCC developed in the medial canthal region. Table 1 
shows the study group characteristics according to the 
recurrence.
The average follow-up time was 37 months with 
a median follow-up time of 22 months (minimum 
1 month, maximum 130 months).
One hundred thirty patients were operated under 
general and 28 under local anaesthesia. As a rule, after 
excision of cancer, all surgical instruments as well as sur-
gical gloves of the team were changed to prevent the 
transfer of tumour cells. In 66 (41.77%) patients, BCC 
was radically removed. In 50 (31.65%) patients BCC was 
removed with a narrow margin and in 42 (26.58%) of 
cases, radical excision was not achieved. In the group 
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of incomplete excision of BCC, 13 patients were reop-
erated and in 9 patients excisional biopsy of the scar 
was performed during the second stage of treatment. 
In all cases BCC cells were not found in histopathological 
examination. Twenty patients refused to have proposed 
reoperation, but agreed to more frequent check-ups 
in our outpatient clinic.
Recurrence of BCC was observed in 6 (3.8%) patients. 
The average time to recurrence was 26 months, and the 
median was 8 months (range: 2–113 months).
Table 1. Study group characteristics according to the 
recurrence





Age 68 (20–95) 66 (51–82)
Sex M : F 76 : 76 4 : 2
Localization:
Medial canthal region 85 3 0.377
Upper eyelid 9 1
Lower eyelid 50 1
Lateral canthal region 8 1
TNM:





Radical 66 0 0.002
Narrow margins 50 0
Non-radical 36 6
Histological type:
Aggressive 15 5 0.027
Non-aggressive 137 1
Margin involved:
Deep 29 3 0.729
Lateral 32 1
Both 25 2
Table 2. Analysis of risk factors for non-radical excision of BCC
Subtypes N Non-radical excision OR 95% CI P-value
Aggressive subtypes 20 11 1 Ref.
Nonaggressive subtypes 138 31 0.2 0.067 0.601 0.004
Localization N Non-radical excision OR 95% CI P-value
Medial canthal region 88 23 1 Ref.
Lower eyelid 51 11 0.777 0.343 1.763 0.547
Upper eyelid 10 4 1.884 0.488 7.279 0.358
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Figure 2.  Analysis of risk factors for recurrence
Figure 3. Analysis of risk factors for recurrence
Advances in Dermatology and Allergology 6, December/2020930
Krzysztof Gąsiorowski, Katarzyna Iwulska, Jan Zapała, Grażyna Wyszyńska-Pawelec
The recurrence rate was significantly higher in the 
group of aggressive BCC compared to non-aggressive 
(p = 0.004). Five out of six recurrent BCCs were aggres-
sive subtypes, in 3 cases they were morphea type, and in 
2 cases styloid. The recurrence-free rate for nonaggres-
sive subtypes was 98.11% in both the first and fifth year, 
but in aggressive subtypes it was 89.06% in the first year 
but fell to 80.16% in the fifth year (Figure 2).
Another recurrence risk factor is non-radical excision 
of the primary lesion. In our study all recurrences were 
observed after non-radical excision (tumour cells visible 
in the line of excision). There were no recurrences after 
excision with a narrow margin. For non-radical excisions, 
the recurrence-free rate plateaued at 90,08% after one 
year and fell to 86.33% after 5 years (Figure 3). In our 
study we did not find a connection between the margin 
of non-radical excision (lateral or deep) and the recur-
rence rate (p = 0.924). There were no statistically signifi-
cant differences between localization of BCC (p = 0.731), 
tumour staging (p = 0.229) and local recurrence. In the 
analysed group of patients, there was no statistically sig-
nificant correlation between the stage of advancement of 
the lesion and the risk of non-radical excision.
Furthermore, in our study, we found that the aggres-
sive subtype of BCCs is the risk factor for incomplete ex-
cision (p = 0.004). The odds ratio for nonaggressive sub-
types is 0.2. This means the risk of incomplete excision 
is reduced by 80%, and the aggressive subtypes raise the 
risk five times as presented in Table 2.
Discussion
The aim of periocular BCC surgery is to remove the 
tumour while maintaining eyelid functionality and fa-
cial aesthetics. There are several guidelines concerning 
minimal excision margins of periocular BCC. The UK Na-
tional Multidisciplinary Guidelines recommend that non-
infiltrative BCCs < 2 cm should be excised with a margin 
of 4–5 mm. Smaller margins (2–3 mm) may be taken in 
case of limited reconstructive options [4]. Moreover, the 
American Academy of Dermatology and NCCN both rec-
ommend excision of periocular BCC with a 4 mm mar-
gin [3, 5]. However, there are studies that show that the 
histopathological safety margin (HSM) can be less than 
4 mm. Chadha et al. claimed that a recurrence rate of 
BCC excised with 2 mm HSM correlates well with pub-
lished results following conventional excision of BCCs 
[6]. Auw-Haedrich et al. in their study claimed that the 
excision of eyelid BCC with a 0.2 mm margin can prevent 
recurrence of periocular BCC [7].
Although MMS is recommended for high-risk BCC 
by NCCN and other authors, it can be too expensive 
and time-consuming and not every hospital can afford 
it. Moreover, it is not advised to use MMS for BCC with 
deep orbital invasion as it is difficult to obtain correctly 
oriented specimens from orbital soft tissues [8]. Because 
of the limited access to MMS, surgical excision of BCC 
with intraoperative confirmation of margin clearance can 
be successfully used.
In the analysed group of patients, the male-female 
ratio was 1 : 1 with a slight predominance of men and the 
average age was 68 years. This does not differ from the 
analysed literature [4, 8–10]. In our study group, BCC of 
the medial canthal region accounted for 55.7%, followed 
by 32.3% for the lower eyelid. However, in the analysed 
literature the lower eyelid is the most common site (60–
70%), followed by the medial canthal region (26–30%) 
[11–13]. According to analysed literature, frequent in-
volvement of the lower eyelid might be caused by light 
reflection by the cornea onto the lower lid and chronic 
chemical or physical tear irritation. Protection given by 
the eyebrow is said to reduce the risk chance of develop-
ing upper eyelid BCC [14, 15].
In our study, we present a group of 158 patients with 
periocular BCC that underwent standard surgical exci-
sion with a margin of 4 mm of surrounding healthy tis-
sue as the safety margin. The recurrence rate after com-
plete excision of BCC ranges from 5% to 14% [15]. In the 
analysed literature, the recurrence rate after incomplete 
excision of primary periocular BCC ranges from 12% to 
18.9% [9, 11, 16]. In our study, the recurrence rate after in-
complete excision of primary BCC is 14.3%. Consequently, 
with this rate, according to NCCN guidelines, reoperation 
is needed and the treatment of choice is MMS, although 
margin-controlled excision of recurrent BCC can also be 
used [14]. In our practice, we use intraoperative histo-
pathological examination to determine if surgical mar-
gins are clear.
We did not notice recurrences after a radical excision 
and excision with a narrow margin. According to Auw-
Haedrich et al., Chadha et al. and our studies, there is 
no need to reoperate patients treated for BCC with small 
histopathological margins [6, 7]. Nevertheless, patients 
should be advised to have regular check-up visits in an 
outpatient clinic.
The literature describes the relationship between 
the BCC subtype and prognosis as well as the recurrence 
risk after non-radical excision [10]. Based on our analysed 
group of patients, we found that the aggressive subtype 
significantly influences the risk of non-radical excision 
of the lesion, increasing the risk five times. According to 
other authors researched, recurrence after excision of 
nodular and superficial BCC with positive margins can 
vary from 3% to 7%, and for infiltrative BCC, it can reach 
26% [15, 17]. The most common type of BCC in our study 
is the nodular type, and the most common type in re-
current lesions is the morpheaform type. Those data are 
consistent with other studies [10, 11].
In our study we did not find any correlation between 
the site of non-radical excision and the recurrence risk 
(p = 0.924), although Miszczyk et al. found an associa-
tion of a positive lateral margin with a higher risk of 
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recurrence [18]. However, other authors found a corre-
lation between the size of tumour and the recurrence 
risk. Recurrence in larger tumours > 2 cm reaches 23% to 
40% and for smaller tumours decreases to 10% to 12% 
[15]. There are not many publications that show a cor-
relation between the margin of non-radical excision and 
the recurrence rate. However, Lara et al. found a slight 
correlation between involvement of the deep margin and 
a higher recurrence rate of BCC [19]. In another study, Al 
Wohaib et al. proved that incomplete excision is reported 
more often in lateral margin causing a higher risk of re-
currence [15].
Standard follow-up of the patients after BCC exci-
sion should be performed for the first 2 years every 
6 months, for 3–5 years, once a year. However, according 
to NCCN, recommended follow-up should be developed 
every 6–12 months for first 5 years, and then at least 
annually for life [3].
Conclusions
There is no need to reoperate patients with a narrow 
margin of BCC excision. However, these patients should 
be advised to conduct regular self-checks with respect to 
new lesions in other localizations. Aggressive BCC sub-
types significantly affect the risk of a non-radical exci-
sion. Marking the subtype of BCC during the incisional 
biopsy is very important since it helps to choose the best 
method of treatment. Aggressive subtypes of BCC should 
result in more frequent patient check-ups in an outpa-
tient clinic during the first years after surgery. Observa-
tions of the patient should be extended over time be-
cause of the possibility of recurrence even up to 5 years.
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